| Literature DB >> 28435532 |
Nicola Pontillo1, Giarita Ferraro1, John R Helliwell2, Angela Amoresano1, Antonello Merlino1,3.
Abstract
The second-generation Pt anticancer agent carboplatin (CBDCA) was encapsulated within the apo horse spleen ferritin (AFt) nanocage, and the X-ray structure of the drug-loaded protein was refined at 1.49 Å resolution. Two Pt binding sites, different from the one observed in the cisplatin-encapsulated AFt, were identified in Ft subunits by inspection of anomalous electron density maps at two wavelengths and difference Fourier electron density maps, which provide the necessary sensitivity to discriminate between Pt from CBDCA and Cd ions that are present in the crystallization conditions. Pt centers coordinate to the NE2 atom of His49 and to the NE2 atom of His132, both on the inner surface of the Ft nanocage.Entities:
Keywords: Pt-based drugs; carboplatin; encapsulated drugs; ferritin
Year: 2017 PMID: 28435532 PMCID: PMC5392753 DOI: 10.1021/acsmedchemlett.7b00025
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345